Atherosclerosis, acute coronary events, and cholesterol-lowering: a new paradigm

D J Rader1

  • 1Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Insights

Identifying individuals at risk for coronary artery disease is crucial. Many heart attacks stem from non-obvious plaque buildup, highlighting the need for better risk assessment to guide treatment and prevent events.

Area of Science:

  • Cardiovascular Medicine
  • Atherosclerosis Research

Background:

  • Acute coronary events can occur before significant arterial narrowing (stenosis).
  • Most myocardial infarctions arise from lesions with 30-60% stenosis, often asymptomatic.
  • Approximately 200,000 Americans die from their first myocardial infarction annually, many without prior coronary disease history.

Purpose of the Study:

  • To emphasize the importance of identifying individuals at risk for coronary artery disease.
  • To highlight the critical role of risk assessment in guiding therapeutic decisions.
  • To inform strategies for reducing acute coronary events and associated mortality.

Main Methods:

  • Review of current understanding of acute coronary event mechanisms.
  • Analysis of recent studies on myocardial infarction causes.
  • Examination of the implications of asymptomatic coronary lesions.

Main Results:

  • Coronary atherosclerotic plaques do not require severe stenosis to cause acute events.
  • A significant proportion of myocardial infarctions originate from moderately stenotic, asymptomatic lesions.
  • Current risk assessment methods are insufficient for identifying many individuals susceptible to first-time heart attacks.

Conclusions:

  • Early identification of individuals at risk for coronary artery disease is paramount.
  • Improved risk assessment is essential for effective lipid-lowering therapy decisions.
  • Developing better strategies to prevent acute coronary events is a critical public health goal.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...